These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8058317)

  • 21. Oxidized LDL induces transcription factor activator protein-1 in rat mesangial cells.
    Wu ZL; Wang YC; Zhou Q; Ge YQ; Lan Y
    Cell Biochem Funct; 2003 Sep; 21(3):249-56. PubMed ID: 12910478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of murine fra-1: induction mediated by CD40 and surface Ig is protein kinase C dependent.
    Huo L; Rothstein TL
    J Immunol; 1996 Nov; 157(9):3812-8. PubMed ID: 8892610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cadmium induces phosphorylation and stabilization of c-Fos in HK-2 renal proximal tubular cells.
    Iwatsuki M; Inageda K; Matsuoka M
    Toxicol Appl Pharmacol; 2011 Mar; 251(3):209-16. PubMed ID: 21219922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fos is phosphorylated by p34cdc2, cAMP-dependent protein kinase and protein kinase C at multiple sites clustered within regulatory regions.
    Abate C; Marshak DR; Curran T
    Oncogene; 1991 Dec; 6(12):2179-85. PubMed ID: 1766667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue-specific expression of the fos-related transcription factor fra-2 during mouse development.
    Carrasco D; Bravo R
    Oncogene; 1995 Mar; 10(6):1069-79. PubMed ID: 7700631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different types of modification in c-fos and its associated protein p39: modulation of DNA binding by phosphorylation.
    Müller R; Bravo R; Müller D; Kurz C; Renz M
    Oncogene Res; 1987; 2(1):19-32. PubMed ID: 3146046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic interactions of c-fos protein in serum-stimulated 3T3 cells.
    Vosatka RJ; Hermanowski-Vosatka A; Metz R; Ziff EB
    J Cell Physiol; 1989 Mar; 138(3):493-502. PubMed ID: 2494195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphate-dependent regulation of MGP in osteoblasts: role of ERK1/2 and Fra-1.
    Julien M; Khoshniat S; Lacreusette A; Gatius M; Bozec A; Wagner EF; Wittrant Y; Masson M; Weiss P; Beck L; Magne D; Guicheux J
    J Bone Miner Res; 2009 Nov; 24(11):1856-68. PubMed ID: 19419315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of c-fos and c-jun mRNA at the M/G1 border is required for cell cycle progression.
    Cosenza SC; Yumet G; Soprano DR; Soprano KJ
    J Cell Biochem; 1994 Aug; 55(4):503-12. PubMed ID: 7962180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse.
    Pandey S; Wang E
    J Cell Biochem; 1995 Jun; 58(2):135-50. PubMed ID: 7673322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning and characterisation of the mouse fra-2 gene.
    Foletta VC; Sonobe MH; Suzuki T; Endo T; Iba H; Cohen DR
    Oncogene; 1994 Nov; 9(11):3305-11. PubMed ID: 7936655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Existence of different Fos/Jun complexes during the G0-to-G1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins.
    Kovary K; Bravo R
    Mol Cell Biol; 1992 Nov; 12(11):5015-23. PubMed ID: 1406676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue-specific transgenic knockdown of Fos-related antigen 2 (Fra-2) expression mediated by dominant negative Fra-2.
    Smith M; Burke Z; Humphries A; Wells T; Klein D; Carter D; Baler R
    Mol Cell Biol; 2001 Jun; 21(11):3704-13. PubMed ID: 11340164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of c-Fos as a mitotic phosphoprotein: regulation of c-Fos by Aurora-A.
    Yu CT; Wu JC; Liao MC; Hsu SL; Huang CY
    J Biomed Sci; 2008 Jan; 15(1):79-87. PubMed ID: 17926144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of the c-fos(rat) cDNA and analysis of post-translational modification in vitro.
    Curran T; Gordon MB; Rubino KL; Sambucetti LC
    Oncogene; 1987; 2(1):79-84. PubMed ID: 3325886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase.
    Chen RH; Abate C; Blenis J
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):10952-6. PubMed ID: 8248197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The kinase c-Src and the phosphatase TC45 coordinately regulate c-Fos tyrosine phosphorylation and c-Fos phospholipid synthesis activation capacity.
    Ferrero GO; Velazquez FN; Caputto BL
    Oncogene; 2012 Jul; 31(28):3381-91. PubMed ID: 22105363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry.
    Burch PM; Yuan Z; Loonen A; Heintz NH
    Mol Cell Biol; 2004 Jun; 24(11):4696-709. PubMed ID: 15143165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fos family members: regulation, structure and role in oncogenic transformation.
    Tulchinsky E
    Histol Histopathol; 2000 Jul; 15(3):921-8. PubMed ID: 10963134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell cycle and cyclic AMP-dependent phosphorylation of plasma membrane proteins p14 and p24: defects in smooth surface transformed cells.
    Boman BM; Zschunke MA; Scott RE
    J Cell Biochem; 1983; 23(1-4):203-9. PubMed ID: 6327739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.